Ghergurovich, Jonathan M. http://orcid.org/0000-0002-6565-2275
Xu, Xincheng
Wang, Joshua Z. http://orcid.org/0000-0003-0319-8967
Yang, Lifeng
Ryseck, Rolf-Peter
Wang, Lin http://orcid.org/0000-0002-9370-6891
Rabinowitz, Joshua D. http://orcid.org/0000-0002-1247-4727
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01 CA163591)
U.S. Department of Health & Human Services | National Institutes of Health (1DP1DK113643)
Article History
Received: 2 October 2020
Accepted: 1 September 2021
First Online: 18 November 2021
Competing interests
: J.D.R. is a paid adviser and stockholder in Kadmon Pharmaceuticals, L.E.A.F. Pharmaceuticals and Rafael Pharmaceuticals; a paid consultant of Pfizer; a founder, director, and stockholder of Farber Partners and Serien Therapeutics. J.D.R. and J.M.G. are inventors of patents in the area of folate metabolism held by Princeton University. The other authors declare no competing interests.